Age-related mortality in 61,993 confirmed COVID-19 cases over three epidemic waves in Aragon, Spain. Implications for vaccination programmes

PLoS One. 2021 Dec 9;16(12):e0261061. doi: 10.1371/journal.pone.0261061. eCollection 2021.

Abstract

Background: Risk for severe COVID-19 increases with age. Different vaccination strategies are currently being considered, including those aimed at slowing down transmission and those aimed at providing direct protection to those most at risk.

Methods: The objectives of the current study were i) to assess age-related incidence and survival between PCR-diagnosed COVID-19 cases (n = 61,993) in the Autonomous Community of Aragon from March to November 2020, and ii) to characterize age differences regarding the course of the disease in hospitalized patients in a tertiary university hospital.

Results: We found a similar incidence of COVID-19 in individuals between 10 and 79 years. Incidence increased in those over 80 years possibly because of the elevated transmission within the nursing homes. We observed a profound disparity among age groups; case fatality rates (CFRs) were near 0 in cases younger than 39 years throughout different waves. In contrast, there was an age-dependent and progressive increase in the CFRs, especially during the first pandemic wave. SARS-CoV-2 infection caused a more severe and rapid progression in older patients. The elderly required faster hospitalization, presented more serious symptoms on admission, and had a worse clinical course. Hospitalized older individuals, even without comorbidities, had an increased mortality risk directly associated with their age. Lastly, the existence of comorbidities dramatically increased the CFRs in the elderly, especially in males.

Conclusion: The elevated incidence of COVID-19 and the vulnerability of the elderly call for their prioritization in vaccination and targeted prevention measures specifically focused on this aged population.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Age Factors
  • Aged
  • Aged, 80 and over
  • COVID-19 / epidemiology*
  • COVID-19 / mortality
  • COVID-19 / virology
  • Child
  • Comorbidity
  • Female
  • Humans
  • Immunization Programs*
  • Incidence
  • Male
  • Middle Aged
  • SARS-CoV-2 / isolation & purification
  • Spain / epidemiology
  • Survival Analysis
  • Young Adult

Grants and funding

JMA-M is partially supported by the project PI17/02268 (Instituto de Salud Carlos III and co-financed by Fondo Europeo de Desarrollo Regional (FEDER): “Una manera de hacer Europa”) and by the DGA Group Biology of adipose tissue and metabolic complications (B03_20R), co-financed with the FEDER Aragón 2014-2020: “Construyendo Europa desde Aragón”. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.